LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 13 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $79,308,000 | +28.1% | 22,500,000 | 0.0% | 6.24% | +57.7% |
| Q2 2018 | $61,897,000 | +109.5% | 22,500,000 | +66.7% | 3.96% | +153.9% |
| Q1 2018 | $29,542,000 | -39.9% | 13,500,000 | -50.0% | 1.56% | +14.3% |
| Q4 2017 | $49,190,000 | +99.7% | 27,000,000 | +100.0% | 1.36% | +18.9% |
| Q3 2017 | $24,629,000 | +75.1% | 13,500,000 | +58.8% | 1.15% | +66.1% |
| Q2 2017 | $14,068,000 | +34.9% | 8,500,000 | +21.4% | 0.69% | +8.2% |
| Q1 2017 | $10,430,000 | – | 7,000,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 41,855,000 | $69,957,000 | 3.06% |
| Myriad Asset Management Ltd. | 20,000,000 | $33,349,000 | 2.89% |
| TFG Asset Management GP Ltd | 6,000,000 | $10,022,000 | 2.28% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,425,000 | $14,058,000 | 2.18% |
| Opera Trading Capital | 3,700,000 | $6,178,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $37,644,000 | 1.29% |
| Man Investments (CH) AG | 1,000,000 | $1,668,000 | 0.87% |
| Verition Fund Management LLC | 3,200,000 | $5,352,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $40,849,000 | 0.62% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $8,014,000 | 0.29% |